LifeMD (LFMD) Cash from Financing Activities (2012 - 2025)

LifeMD (LFMD) has reported Cash from Financing Activities for 14 consecutive years, with -$788562.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities rose 15.65% year-over-year to -$788562.0; the trailing twelve-month figure through Dec 2025 stood at -$13.4 million (down 225.52% YoY), and the FY2025 full-year result was -$13.4 million, down 225.52% from the prior year.
• Cash from Financing Activities climbed to -$788562.0 in Q4 2025 per LFMD's latest filing, from -$8.7 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $39.3 million in Q4 2021 and bottomed at -$8.7 million in Q3 2025.
• Historically, Cash from Financing Activities has averaged $4.0 million across 5 years, with a median of -$781312.5 in 2022.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 1649.16% in 2023, then tumbled 558.85% in 2025.
• Over 5 years, Cash from Financing Activities stood at $39.3 million in 2021, then slumped by 95.26% to $1.9 million in 2022, then soared by 671.21% to $14.4 million in 2023, then tumbled by 106.51% to -$934903.0 in 2024, then climbed by 15.65% to -$788562.0 in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$788562.0, -$8.7 million, and -$3.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.